LimWH, JohnsonDW, Teixeira-PintoA, WongG: Association between duration of delayed graft function, acute rejection and allograft outcome after deceased donor kidney transplantation. Transplantation103: 412–419, 2019 PubMed
CherukuriA, MehtaR, SoodP, HariharanS: Early allograft inflammation and scarring associate with graft dysfunction and poor outcomes in renal transplant recipients with delayed graft function: A prospective single center cohort study. Transpl Int31: 1369–1379, 2018 PubMed
CherukuriA, MehtaR, SoodP, HariharanS: Early allograft inflammation and scarring associate with graft dysfunction and poor outcomes in renal transplant recipients with delayed graft function: A prospective single center cohort study. Transpl Int 31: 1369–1379, 2018 PubMed10.1111/tri.13318)| false
LimWH, McDonaldSP, RussGR, ChapmanJR, MaMK, PleassH, et al.: Association between delayed graft function and graft loss in donation after cardiac death kidney transplants: A paired kidney registry analysis. Transplantation101: 1139–1143, 2017 PubMed
LimWH, McDonaldSP, RussGR, ChapmanJR, MaMK, PleassH, : Association between delayed graft function and graft loss in donation after cardiac death kidney transplants: A paired kidney registry analysis. Transplantation 101: 1139–1143, 2017 PubMed10.1097/TP.0000000000001323)| false
HeylenL, JochmansI, SamuelU, TiekenI, NaesensM, PirenneJ, et al.: The duration of asystolic ischemia determines the risk of graft failure after circulatory-dead donor kidney transplantation: A Eurotransplant cohort study. Am J Transplant18: 881–889, 2018 PubMed
HeylenL, JochmansI, SamuelU, TiekenI, NaesensM, PirenneJ, : The duration of asystolic ischemia determines the risk of graft failure after circulatory-dead donor kidney transplantation: A Eurotransplant cohort study. Am J Transplant 18: 881–889, 2018 PubMed10.1111/ajt.14526)| false
ScaleaJR, RedfieldRR, ArpaliE, LeversonGE, BennettRJ, AndersonME, et al.: Does DCD donor time-to-death affect recipient outcomes? Implications of time-to-death at a high-volume center in the United States. Am J Transplant17: 191–200, 2017 PubMed
ScaleaJR, RedfieldRR, ArpaliE, LeversonGE, BennettRJ, AndersonME, : Does DCD donor time-to-death affect recipient outcomes? Implications of time-to-death at a high-volume center in the United States. Am J Transplant 17: 191–200, 2017 PubMed10.1111/ajt.13948)| false
BoffaC, van de LeemkolkF, CurnowE, Homan van der HeideJ, GilbertJ, SharplesE, et al.: Transplantation of kidneys from donors with acute kidney injury: Friend or foe?Am J Transplant17: 411–419, 2017 PubMed
BoffaC, van de LeemkolkF, CurnowE, Homan van der HeideJ, GilbertJ, SharplesE, : Transplantation of kidneys from donors with acute kidney injury: Friend or foe? Am J Transplant 17: 411–419, 2017 PubMed10.1111/ajt.13966)| false
OrlandoG, KhanMA, El-HennawyH, FarneyAC, RogersJ, Reeves-DanielA, et al.: Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors?Clin Transplant 32: e13185, 2018 PubMed
SchnuelleP, GottmannU, HoegerS, BoesebeckD, LauchartW, WeissC, et al.: Effects of donor pretreatment with dopamine on graft function after kidney transplantation: A randomized controlled trial. JAMA302: 1067–1075, 2009 PubMed
SchnuelleP, GottmannU, HoegerS, BoesebeckD, LauchartW, WeissC, : Effects of donor pretreatment with dopamine on graft function after kidney transplantation: A randomized controlled trial. JAMA 302: 1067–1075, 2009 PubMed10.1001/jama.2009.1310)| false
SchnuelleP, SchmittWH, WeissC, HabichtA, RendersL, ZeierM, et al.: Effects of dopamine donor pretreatment on graft survival after kidney transplantation: A randomized trial. Clin J Am Soc Nephrol12: 493–501, 2017 PubMed
SchnuelleP, MundtHM, DrüschlerF, SchmittWH, YardBA, KrämerBK, et al.: Impact of spontaneous donor hypothermia on graft outcomes after kidney transplantation. Am J Transplant18: 704–714, 2018 PubMed
NiemannCU, FeinerJ, SwainS, BuntingS, FriedmanM, CrutchfieldM, et al.: Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med373: 405–414, 2015 PubMed
NiemannCU, FeinerJ, SwainS, BuntingS, FriedmanM, CrutchfieldM, : Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med 373: 405–414, 2015 PubMed10.1056/NEJMoa1501969)| false
PatelK, NathJ, HodsonJ, InstonN, ReadyA: Outcomes of donation after circulatory death kidneys undergoing hypothermic machine perfusion following static cold storage: A UK population-based cohort study. Am J Transplant18: 1408–1414, 2018 PubMed
PatelK, NathJ, HodsonJ, InstonN, ReadyA: Outcomes of donation after circulatory death kidneys undergoing hypothermic machine perfusion following static cold storage: A UK population-based cohort study. Am J Transplant 18: 1408–1414, 2018 PubMed10.1111/ajt.14587)| false
KoxJ, MoersC, MonbaliuD, StrelnieceA, TreckmannJ, JochmansI, et al.: The benefits of hypothermic machine preservation and short cold ischemia times in deceased donor kidneys. Transplantation102: 1344–1350, 2018 PubMed
KoxJ, MoersC, MonbaliuD, StrelnieceA, TreckmannJ, JochmansI, : The benefits of hypothermic machine preservation and short cold ischemia times in deceased donor kidneys. Transplantation 102: 1344–1350, 2018 PubMed10.1097/TP.0000000000002188)| false
SchnuelleP, DrüschlerK, SchmittWH, BenckU, ZeierM, KrämerBK, et al.: Donor organ intervention before kidney transplantation: Head-to-head comparison of therapeutic hypothermia, machine perfusion, and donor dopamine pretreatment. What is the evidence?Am J Transplant19: 975–983, 2019 PubMed
SchnuelleP, DrüschlerK, SchmittWH, BenckU, ZeierM, KrämerBK, : Donor organ intervention before kidney transplantation: Head-to-head comparison of therapeutic hypothermia, machine perfusion, and donor dopamine pretreatment. What is the evidence? Am J Transplant 19: 975–983, 2019 PubMed10.1111/ajt.15317)| false
van BalkomBWM, GremmelsH, OomsLSS, TooropRJ, DorFJMF, de JongOG, et al.: Proteins in preservation fluid as predictors of delayed graft function in kidneys from donors after circulatory death. Clin J Am Soc Nephrol12: 817–824, 2017 PubMed
van BalkomBWM, GremmelsH, OomsLSS, TooropRJ, DorFJMF, de JongOG, : Proteins in preservation fluid as predictors of delayed graft function in kidneys from donors after circulatory death. Clin J Am Soc Nephrol 12: 817–824, 2017 PubMed10.2215/CJN.10701016)| false
JordanSC, ChoiJ, AubertO, HaasM, LoupyA, HuangE, et al.: A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. Am J Transplant18: 2955–2964, 2018 PubMed
JordanSC, ChoiJ, AubertO, HaasM, LoupyA, HuangE, : A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. Am J Transplant 18: 2955–2964, 2018 PubMed10.1111/ajt.14767)| false
KrogstrupNV, OlteanM, Nieuwenhuijs-MoekeGJ, DorFJ, MøldrupU, KragSP, et al.: Remote ischemic conditioning on recipients of deceased renal transplants does not improve early graft function: A multicenter randomized, controlled clinical trial. Am J Transplant17: 1042–1049, 2017 PubMed
WojciechowskiD, ChandranS, VincentiF: Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Clin Transplant31: 2017 PubMed
WojciechowskiD, ChandranS, VincentiF: Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Clin Transplant 31: 2017 PubMed10.1111/ctr.12930)| false